These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 9918753)

  • 1. Fenfluramine potentiates canine pulmonary vasoreactivity to endothelin-1.
    Barman SA; Isales CM
    Pulm Pharmacol Ther; 1998; 11(2-3):183-7. PubMed ID: 9918753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anorexic agents aminorex, fenfluramine, and dexfenfluramine inhibit potassium current in rat pulmonary vascular smooth muscle and cause pulmonary vasoconstriction.
    Weir EK; Reeve HL; Huang JM; Michelakis E; Nelson DP; Hampl V; Archer SL
    Circulation; 1996 Nov; 94(9):2216-20. PubMed ID: 8901674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Valvular heart disease and primary pulmonary hypertension associated with fenfluramine-phentermine].
    Wolf I; Mouallem M; Farfel Z
    Harefuah; 1998 Dec; 135(11):515-7. PubMed ID: 10911468
    [No Abstract]   [Full Text] [Related]  

  • 4. On the role of serotonin in the pathogenesis of pulmonary hypertension induced by anorectic drugs; an experimental study in the isolated perfused rat lung, II. Fenfluramine, mazindol, mefenorex, phentermine and R 800.
    Seiler KU; Wassermann O; Wensky H
    Clin Exp Pharmacol Physiol; 1976; 3(4):323-30. PubMed ID: 975621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of dexfenfluramine treatment in rats exposed to acute and chronic hypoxia.
    Eddahibi S; Raffestin B; Launay JM; Sitbon M; Adnot S
    Am J Respir Crit Care Med; 1998 Apr; 157(4 Pt 1):1111-9. PubMed ID: 9563727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-induced pulmonary hypertension: must history repeat itself?
    Voelkel NF
    Pulm Pharmacol; 1996 Apr; 9(2):67-8. PubMed ID: 8880947
    [No Abstract]   [Full Text] [Related]  

  • 7. Brain serotonin neurotoxicity and primary pulmonary hypertension from fenfluramine and dexfenfluramine. A systematic review of the evidence.
    McCann UD; Seiden LS; Rubin LJ; Ricaurte GA
    JAMA; 1997 Aug; 278(8):666-72. PubMed ID: 9272900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fenfluramine: riddle or Rosetta stone?
    Weir EK; Obreztchikova M; Hong Z
    Eur Respir J; 2008 Feb; 31(2):232-5. PubMed ID: 18238944
    [No Abstract]   [Full Text] [Related]  

  • 9. [Anorectics and pulmonary hypertension].
    Bíbová J; Hampl V
    Cas Lek Cesk; 2000 Feb; 139(3):67-70. PubMed ID: 10838744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute and chronic effects of dexfenfluramine on the porcine pulmonary artery.
    Desta B; Steed S; Ravel D; Laudignon N; Vanhoutte PM; Boulanger CM
    Gen Pharmacol; 1998 Mar; 30(3):403-10. PubMed ID: 9510094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fenfluramine-induced pulmonary vasoconstriction: role of serotonin receptors and potassium channels.
    Belohlávková S; Simák J; Kokesová A; Hnilicková O; Hampl V
    J Appl Physiol (1985); 2001 Aug; 91(2):755-61. PubMed ID: 11457791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complex vascular lesions at autopsy in a patient with phentermine-fenfluramine use and rapidly progressing pulmonary hypertension.
    Strother J; Fedullo P; Yi ES; Masliah E
    Arch Pathol Lab Med; 1999 Jun; 123(6):539-40. PubMed ID: 10383810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary hypertension, anorexigens and 5-HT: pharmacological synergism in action?
    MacLean MR
    Trends Pharmacol Sci; 1999 Dec; 20(12):490-5. PubMed ID: 10603491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluoxetine is a safer alternative to fenfluramine in the medical treatment of obesity.
    Anchors M
    Arch Intern Med; 1997 Jun; 157(11):1270. PubMed ID: 9183245
    [No Abstract]   [Full Text] [Related]  

  • 15. Nonpeptide endothelin receptor antagonists. VIII: attentuation of acute hypoxia-induced pulmonary hypertension in the dog.
    Willette RN; Ohlstein EH; Mitchell MP; Sauermelch CF; Beck GR; Luttmann MA; Hay DW
    J Pharmacol Exp Ther; 1997 Feb; 280(2):695-701. PubMed ID: 9023281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A role for potassium channels in smooth muscle cells and platelets in the etiology of primary pulmonary hypertension.
    Weir EK; Reeve HL; Johnson G; Michelakis ED; Nelson DP; Archer SL
    Chest; 1998 Sep; 114(3 Suppl):200S-204S. PubMed ID: 9741569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selections from current literature: pharmacological treatment of obesity.
    Connolly J; Verni C; Trilling J; Kelso E; Shiesha S
    Fam Pract; 1998 Feb; 15(1):88-93. PubMed ID: 9527304
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of dexfenfluramine on hypoxic pulmonary vasoconstriction and embolic pulmonary hypertension in dogs.
    Naeije R; Wauthy P; Maggiorini M; Leeman M; Delcroix M
    Am J Respir Crit Care Med; 1995 Mar; 151(3 Pt 1):692-7. PubMed ID: 7881658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic interactions between fenfluramine and phentermine.
    Wellman PJ; Maher TJ
    Int J Obes Relat Metab Disord; 1999 Jul; 23(7):723-32. PubMed ID: 10454106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Development of pulmonary hypertension and multi-valvular damage caused by appetite depressants].
    Goldstein SE; Levy Y; Shoenfeld Y
    Harefuah; 1998 Dec; 135(11):489-92, 568. PubMed ID: 10911459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.